Nexcelom Bioscience's Private Equity Round

Nexcelom Bioscience raised a round of funding on March 20, 2018. Investors include Ampersand Capital Partners.

Nexcelom Bioscience designs, develops, and manufactures devices and instruments for cell-based assays used in cancer research, vaccine development, stem cell research, infectious disease treatment, an…

Articles about Nexcelom Bioscience's Private Equity Round: